Home » Topics » Regulatory

Regulatory
RSS

Accelerated approval for Prezista in HIV combination therapy

June 26, 2006

European approval of Acomplia

June 23, 2006

Avastin approved for second-line use in metastatic colorectal cancer

June 21, 2006

Hycamtin approved for use with cisplatin in cervical cancer

June 19, 2006

Humira approved in Europe for ankylosing spondylitis

June 8, 2006

Betaferon approved in Europe as first-line treatment for earliest stages of MS

June 8, 2006

Zetia approved for use in combination with fenofibrate

May 30, 2006

Cubicin approved for S. aureus bloodstream infections

May 29, 2006

Zostavax approved in U.S. for prevention of shingles

May 29, 2006

Seasonique extended-cycle oral contraceptive receives FDA approval

May 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...